The Travelers Companies, Inc. (NYSE:TRV) Stake Cut by Legacy Trust

Legacy Trust decreased its holdings in shares of The Travelers Companies, Inc. (NYSE:TRV) by 12.0% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 1,051 shares of the insurance provider’s stock after selling 143 shares during the period. Legacy Trust’s holdings in Travelers Companies were worth $253,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently modified their holdings of the business. Wolff Wiese Magana LLC raised its stake in Travelers Companies by 39.1% during the third quarter. Wolff Wiese Magana LLC now owns 160 shares of the insurance provider’s stock worth $37,000 after acquiring an additional 45 shares during the period. True Wealth Design LLC bought a new position in shares of Travelers Companies during the third quarter valued at approximately $41,000. Catalyst Capital Advisors LLC acquired a new stake in shares of Travelers Companies during the 3rd quarter worth approximately $50,000. Versant Capital Management Inc lifted its holdings in shares of Travelers Companies by 581.1% in the 4th quarter. Versant Capital Management Inc now owns 252 shares of the insurance provider’s stock worth $61,000 after purchasing an additional 215 shares during the last quarter. Finally, Salomon & Ludwin LLC lifted its holdings in shares of Travelers Companies by 22.1% in the 3rd quarter. Salomon & Ludwin LLC now owns 276 shares of the insurance provider’s stock worth $65,000 after purchasing an additional 50 shares during the last quarter. 82.45% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In other Travelers Companies news, Vice Chairman William H. Heyman sold 3,740 shares of the business’s stock in a transaction on Monday, November 25th. The shares were sold at an average price of $264.80, for a total transaction of $990,352.00. Following the sale, the insider now directly owns 250,384 shares of the company’s stock, valued at $66,301,683.20. The trade was a 1.47 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Maria Olivo sold 10,410 shares of the firm’s stock in a transaction on Monday, November 18th. The stock was sold at an average price of $261.80, for a total value of $2,725,338.00. Following the completion of the sale, the executive vice president now directly owns 111,162 shares of the company’s stock, valued at approximately $29,102,211.60. This trade represents a 8.56 % decrease in their position. The disclosure for this sale can be found here. Insiders own 1.33% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have weighed in on TRV shares. HSBC raised Travelers Companies from a “hold” rating to a “buy” rating and set a $290.00 target price on the stock in a research report on Tuesday, December 10th. BMO Capital Markets increased their price objective on shares of Travelers Companies from $275.00 to $297.00 and gave the stock an “outperform” rating in a report on Friday, January 24th. Jefferies Financial Group boosted their target price on shares of Travelers Companies from $210.00 to $235.00 and gave the company a “hold” rating in a research note on Wednesday, October 9th. Barclays upped their target price on shares of Travelers Companies from $278.00 to $287.00 and gave the stock an “overweight” rating in a research report on Friday, January 24th. Finally, UBS Group lifted their price target on Travelers Companies from $244.00 to $270.00 and gave the company a “neutral” rating in a report on Tuesday, October 22nd. Four analysts have rated the stock with a sell rating, twelve have assigned a hold rating, seven have given a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $260.47.

Travelers Companies Price Performance

Shares of NYSE TRV opened at $249.85 on Thursday. The Travelers Companies, Inc. has a twelve month low of $200.21 and a twelve month high of $269.55. The company has a current ratio of 0.33, a quick ratio of 0.34 and a debt-to-equity ratio of 0.29. The firm has a 50-day moving average of $247.48 and a two-hundred day moving average of $238.07. The company has a market capitalization of $56.72 billion, a price-to-earnings ratio of 11.64, a PEG ratio of 1.09 and a beta of 0.65.

Travelers Companies (NYSE:TRV) last released its earnings results on Wednesday, January 22nd. The insurance provider reported $9.15 EPS for the quarter, beating the consensus estimate of $6.50 by $2.65. The business had revenue of $12.01 billion during the quarter, compared to analyst estimates of $10.80 billion. Travelers Companies had a net margin of 10.77% and a return on equity of 19.06%. The business’s quarterly revenue was up 9.9% on a year-over-year basis. During the same period in the prior year, the business earned $7.01 earnings per share. As a group, analysts expect that The Travelers Companies, Inc. will post 20.33 earnings per share for the current fiscal year.

Travelers Companies Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Monday, March 31st. Stockholders of record on Monday, March 10th will be paid a dividend of $1.05 per share. This represents a $4.20 annualized dividend and a dividend yield of 1.68%. The ex-dividend date is Monday, March 10th. Travelers Companies’s dividend payout ratio is presently 19.56%.

Travelers Companies Profile

The Travelers Companies, Inc, through its subsidiaries, provides a range of commercial and personal property, and casualty insurance products and services to businesses, government units, associations, and individuals in the United States and internationally. The company operates through three segments: Business Insurance, Bond & Specialty Insurance, and Personal Insurance.